Prophylaxis for respiratory syncytial virus bronchiolitis.
Nadal
D
D
Berger
C
C
Aebi
C
C
Kind
C
C
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D001990:Bronchiolitis, Viral / Q000517:prevention & control*; D003428:Cross Infection / Q000517:prevention & control; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000517:prevention & control*; D000069455:Palivizumab; D012121:Respiration, Artificial; D018357:Respiratory Syncytial Virus Infections / Q000517:prevention & control*; D012136:Respiratory Syncytial Viruses / Q000276:immunology
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069455:Palivizumab